Simin Namvar Aghdash
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Simin Namvar Aghdash has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Soheila Nasirifard
2 shared publicationsAmir Pashaei
1 shared publication- Fahimeh Farshi Azhar
Department of Chemistry, Faculty of Basic Sciences, Azarbaijan Shahid Madani University, Tabriz, Iran
1 shared publication - Farhad Jadidi-Niaragh
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
1 shared publication - Mahsa Nikdel Khosroshahi1 shared publication
- Mina Mohammadzadeh1 shared publication
Latest Publications
- Open Access
- 29 July 2026
- Published by Galenos Yayinevi in Archives Of Epilepsy
- Vol. 32 (3) , 82-90
In Vivo and In Silico Study of Lavender Extract in Pentylenetetrazol-induced Seizures Compared to Diazepam and Phenytoin in Male Mice
In Vivo and In Silico Study of Lavender Extract in Pentylenetetrazol-induced Seizures Compared to Diazepam and Phenytoin in Male Mice - Archives of Epilepsy
- 29 July 2026
- Published by Galenos Yayinevi in Archives Of Epilepsy
- Vol. 32 (3) , 82-90
Open AccessIn Vivo and In Silico Study of Lavender Extract in Pentylenetetrazol-induced Seizures Compared to Diazepam and Phenytoin in Male Mice
In Vivo and In Silico Study of Lavender Extract in Pentylenetetrazol-induced Seizures Compared to Diazepam and Phenytoin in Male Mice - Archives of Epilepsy
- 1 November 2024
- Published by National Academy of Sciences of Tajikistan
- Vol. 13 (2)
The effect of inhibition of interleukin 6 along with the drug doxorubicin on gene expression BIM, BAX, Bcl-2
- 1 November 2024
- Published by National Academy of Sciences of Tajikistan
- Vol. 13 (2)
The effect of inhibition of interleukin 6 along with the drug doxorubicin on gene expression BIM, BAX, Bcl-2
- 17 February 2021
- Published by Bentham Science Publishers Ltd. in Current Drug Targets
- Vol. 22 (3) , 356-367
Herbal Medicine in the Treatment of Epilepsy
Epilepsy is one of the most common disorders of the central nervous system. Although epilepsy is common worldwide, approximately 80% of epileptic patients live in the developing countries or those with low-middle income. Up until the second decade of the 20th century, epilepsy was treated mostly by traditional remedies. Today, antiepileptic drugs are used as a general treatment instead to prevent and control epileptic seizures. However, patient access to these drugs is hindered due to the healthcare systems of their countries and a number of other reasons, such as cultural, socio-demographic, and financial poverty. In addition, approximately 30-40%of epileptic patients suffer from refractory epilepsy, additionally, AEDs have adverse side-effects that can lead to treatment failure or reduce the patient’s quality of life. Despite recent advances in the treatment of epilepsy, there is still a need for improving medical treatment with a particular focus on efficacy, safety, and accessibility. Since herbal medicines have been used for many centuries around the world for treating epilepsy, it is, therefore, plausible that a rigorous study on herbal medicine and phytochemical components within plants of various species and origin may lead to the discovery of novel AEDs. Nowadays, many medicinal plants used in different cultures and regions of the world have been identified. Most phytochemical components of these plants have been identified and, in some cases, their targets located. Therefore, it is possible that new, effective, and accessible anticonvulsants drugs can be obtained from a medicinal plant.
- 17 February 2021
- Published by Bentham Science Publishers Ltd. in Current Drug Targets
- Vol. 22 (3) , 356-367
Herbal Medicine in the Treatment of Epilepsy
Epilepsy is one of the most common disorders of the central nervous system. Although epilepsy is common worldwide, approximately 80% of epileptic patients live in the developing countries or those with low-middle income. Up until the second decade of the 20th century, epilepsy was treated mostly by traditional remedies. Today, antiepileptic drugs are used as a general treatment instead to prevent and control epileptic seizures. However, patient access to these drugs is hindered due to the healthcare systems of their countries and a number of other reasons, such as cultural, socio-demographic, and financial poverty. In addition, approximately 30-40%of epileptic patients suffer from refractory epilepsy, additionally, AEDs have adverse side-effects that can lead to treatment failure or reduce the patient’s quality of life. Despite recent advances in the treatment of epilepsy, there is still a need for improving medical treatment with a particular focus on efficacy, safety, and accessibility. Since herbal medicines have been used for many centuries around the world for treating epilepsy, it is, therefore, plausible that a rigorous study on herbal medicine and phytochemical components within plants of various species and origin may lead to the discovery of novel AEDs. Nowadays, many medicinal plants used in different cultures and regions of the world have been identified. Most phytochemical components of these plants have been identified and, in some cases, their targets located. Therefore, it is possible that new, effective, and accessible anticonvulsants drugs can be obtained from a medicinal plant.
- Open Access
- 1 June 2015
- Published by CASRP: Center of Advanced Scientific Research and Publications in The Neuroscience Journal of Shefaye Khatam
- Vol. 3 (2) , 49-54
Assessment of Aqueous Extract of Humulus Lupulus Effects on Seizure Induced by Intraperitoneal Injection of Pentylenetetrazole in Mice
Introduction: Epilepsy is one of the most common disorders of the brain, affecting at least 50 million persons worldwide. Despite a variety of current antiepileptic drugs, research for discovering new drugs with more efficacies and less side effects has been continued. Herbal medicine has various natural substances and proper context for this type of research. The aim of this study was to investigate the effect of Humulus lupulus (Hops) extract on seizure attacks in an experimental animal model. Materials and Methods: 40 male mice have been chosen randomly and divided into 5 groups; including control group, sham group, and three experimental groups. Treated mice received aqueous extract of Humulus lupulus via gavage at doses of 200, 400, and 600 mg/kg for 4 weeks. Thirty minutes after gavage with different doses of the herb or distilled water (sham mice), pentylenetetrazole (PTZ; 45mg/kg) was injected intraperitoneally. Animals immediately transferred to a special cage and the seizure behaviors were recorded by a camera during a 25 minutes period. Results: Data analysis indicated that the aqueous extract of Humulus lupulus had a significant inhibitory effect on PTZ-induced seizure. Treatment with Humulus lupulus significantly increased the latency of seizure onset, decreased the intensity of seizure, and seizure duration. Conclusion: The attained results showed that Hops extract has anticonvulsant effect on PTZ-induced seizure and may be useful for treatment of epilepsy.
- 1 June 2015
- Published by CASRP: Center of Advanced Scientific Research and Publications in The Neuroscience Journal of Shefaye Khatam
- Vol. 3 (2) , 49-54
Open AccessAssessment of Aqueous Extract of Humulus Lupulus Effects on Seizure Induced by Intraperitoneal Injection of Pentylenetetrazole in Mice
Introduction: Epilepsy is one of the most common disorders of the brain, affecting at least 50 million persons worldwide. Despite a variety of current antiepileptic drugs, research for discovering new drugs with more efficacies and less side effects has been continued. Herbal medicine has various natural substances and proper context for this type of research. The aim of this study was to investigate the effect of Humulus lupulus (Hops) extract on seizure attacks in an experimental animal model. Materials and Methods: 40 male mice have been chosen randomly and divided into 5 groups; including control group, sham group, and three experimental groups. Treated mice received aqueous extract of Humulus lupulus via gavage at doses of 200, 400, and 600 mg/kg for 4 weeks. Thirty minutes after gavage with different doses of the herb or distilled water (sham mice), pentylenetetrazole (PTZ; 45mg/kg) was injected intraperitoneally. Animals immediately transferred to a special cage and the seizure behaviors were recorded by a camera during a 25 minutes period. Results: Data analysis indicated that the aqueous extract of Humulus lupulus had a significant inhibitory effect on PTZ-induced seizure. Treatment with Humulus lupulus significantly increased the latency of seizure onset, decreased the intensity of seizure, and seizure duration. Conclusion: The attained results showed that Hops extract has anticonvulsant effect on PTZ-induced seizure and may be useful for treatment of epilepsy.
- Open Access
- 1 June 2015
- Published by CASRP: Center of Advanced Scientific Research and Publications in The Neuroscience Journal of Shefaye Khatam
- Vol. 3 (2) , 35-40
The Effect of Equeous Datura Stramonium L Seed Extract on Chemical Kindling Induced by Intraperitoneal Injection of Pentylenetetrazole in Mice
- 1 June 2015
- Published by CASRP: Center of Advanced Scientific Research and Publications in The Neuroscience Journal of Shefaye Khatam
- Vol. 3 (2) , 35-40
Open AccessThe Effect of Equeous Datura Stramonium L Seed Extract on Chemical Kindling Induced by Intraperitoneal Injection of Pentylenetetrazole in Mice